This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
This product is temporarily unavailable.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
HealthylifeHealthylife is a generic version of Strattera, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). It contains the active ingredient atomoxetine, which belongs to a class of drugs called non-benzodiazepines. These are typically used to increase attention, reduce impulsivity, and increase a child's ability to pay attention. Side effects of Healthylife can include nausea, headache, dizziness, dry mouth, and drowsiness. If you are experiencing a health condition, it is crucial to seek medical advice before using this medication.
Healthylife works by blocking the enzyme that converts norepinephrine into dopamine, which is involved in controlling attention, impulsivity, and hyperactivity. Norepinephrine is involved in regulating the reward and pleasure of the brain. Dopamine plays a role in attention, impulsivity, and hyperactivity. Healthylife works by blocking the action of norepinephrine receptors in the brain, which are involved in controlling attention, impulsivity, and hyperactivity. This helps to increase alertness, reduce hyperactivity, and improve focus. If you are experiencing a health condition, seek medical advice before using this medication.
Healthylife is not intended for use by individuals under the age of 18 years. If you are pregnant or planning to become pregnant, then Healthylife is not recommended. If you are allergic to atomoxetine or any other ingredient in Healthylife, then Healthylife is not intended for use in individuals under the age of 18 years. If you are using any medications, including supplements, please consult with your doctor before using this medication.This medication is typically taken orally with a full glass of water. If you are taking this medication by mouth, please read the instructions carefully and do not take the medication with more than one dose. If you are taking this medication by mouth with a small amount of water, then please drink the entire amount of water before taking this medication. Please do not crush or chew this medication. If you have difficulty swallowing or if the packaging looks different from before you take this medication, then do not swallow the tablet. It is important to follow the directions for use for proper use of this medication.
This medication may cause serious side effects. If you experience any severe or persistent side effects, you should seek immediate medical attention.
Healthylife contains atomoxetine and dofetilane, which are both derived from opium, and drosophila, which is a derivative of the opium poppy. The combination of these two medications is particularly useful for individuals with attention deficit hyperactivity disorder (ADHD). If you have not taken this medication before, then Healthylife is not intended for use in combination with this medication. This medication is also not intended for immediate release, as it is rapidly absorbed from the body into the bloodstream and is rapidly eliminated from the body.
How Effective is Strattera for ADHD?
Strattera is a selective norepinephrine reuptake inhibitor (SNRI) medication that is prescribed to treat attention-deficit hyperactivity disorder (ADHD). It is a selective norepinephrine reuptake inhibitor (SNRI) that works by increasing the amount of norepinephrine available in the brain, which helps to improve attention, behavior, and impulse control.
Strattera is available in various forms and strengths, including Strattera SR (atypical/extended-release), Strattera SR (extended-release), Strattera XL (extended-release), and Strattera XR (extended-release). In clinical studies, Strattera has been shown to be effective in improving attention, behavior, and impulse control in patients with ADHD.
It is important to note that not all individuals with ADHD will respond to Strattera. Individuals with ADHD may need to adjust their dosage and/or take an alternative medication to treat ADHD. It is also important to note that Strattera is not for everyone, and some people may experience side effects or other risks when taking this medication.
What are the common side effects of Strattera?
Strattera, or atomoxetine, is a selective norepinephrine reuptake inhibitor (SNRI) medication that is prescribed to treat attention-deficit hyperactivity disorder (ADHD). It works by increasing the amount of norepinephrine available in the brain, which helps to improve attention, behavior, and impulse control. Strattera can be used in conjunction with a stimulant or norepinephrine reuptake inhibitor (SNRI) to treat ADHD.
Common side effects may include:
How does Strattera work?
Strattera works by increasing the amount of norepinephrine available in the brain, which helps to improve attention, behavior, and impulse control. Strattera may be prescribed for the following conditions:
How to take Strattera for ADHD?
Strattera is usually taken as a single dose. You should take it once or twice daily, depending on your response to the medication and the severity of your symptoms. The dosage may be gradually increased based on your response. It is important to follow your healthcare provider’s instructions closely when taking Strattera for ADHD.
A study published in the Journal of Neurochemistry in 2018 and the Journal of the American Medical Association in 2022 found that atomoxetine was associated with a small increased risk of stroke, heart attack, or death in individuals receiving either atomoxetine or placebo compared with placebo. This is the first meta-analysis that combines atomoxetine with other medications that are more commonly prescribed.
Although atomoxetine is the first oral non-stimulant drug approved by the Food and Drug Administration for the treatment of attention-deficit/hyperactivity disorder (ADHD) in adults, it has been used off-label for other indications as well. The use of atomoxetine is considered to be safe, and atomoxetine was associated with a small increased risk of developing anorexia nervosa (AN) in children and adolescents. However, the risk was not associated with a history of substance use or substance use disorder in the general population.
The results of this meta-analysis will be published in the Journal of the American Medical Association’s Annual Scientific Meeting.
This is an open-access article distributed under the terms of the Creative Commons AttributionNon-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
A new study,Strattera, a medication to treat attention-deficit/hyperactivity disorder, was designed to examine the risk of ADH in individuals taking atomoxetine compared with placebo. The study, published in the Journal of the American Medical Association, was designed to examine the risk of ADH in individuals taking atomoxetine compared with placebo. Atomoxetine was administered to the participants before breakfast, 2-3 hours after breakfast, and at the end of each day for 12 days.The study design was designed using an open-label extension to a previous study of atomoxetine and other medications for ADHD. The researchers recruited participants with a history of ADHD and an open-label extension of atomoxetine. Participants were randomly assigned to receive atomoxetine, or placebo, in a random order to determine their risk of ADH. The dose of atomoxetine was increased or decreased, depending on the condition, using a range of doses, ranging from 40 to 600 mg daily, from day to day, starting from Day 2 of treatment.
The study was double-blind, placebo-controlled, and included a total of 11 participants with ADHD, 11 with ADHD and 9 with ADHD and an open-label extension of atomoxetine.
All participants received the same daily dose of atomoxetine.
In this study, the researchers recruited participants with a history of substance use and an open-label extension of atomoxetine.
Medically Reviewed by
Dr. Akansha is a licensed Clinical Pharmacologist with extensive expertise in pharmacovigilance, prescription analysis, drug information, and drug safety. She is a frequent contributor to GoodRx, GoodRXPharma, and GoodRXDrugs.com, and is a Certified Healthcare Professional with extensive knowledge in healthcare safety. Akansha also regularly posts on GoodRxDrugs.com, as well as has authored numerous articles on the topic. Akansha also reviews, blogs, and articles on other medical websites as well.
Akansha is a board-certified Pharmacologist with over 15 years of experience in healthcare safety. She specializes in the administration of prescription medications, as well as the treatment of ADHD, narcolepsy, and other conditions. She is a licensed medical professional with extensive knowledge in ADHD medication management and other treatment options. Akansha has written numerous articles on the topic.
What are the side effects of Strattera?
The most commonly reported side effects of Strattera are nausea, headache, and insomnia. Some patients experience increased blood pressure and heart rate, especially in severe cases. The most common side effects of Strattera include drowsiness, dizziness, or dry mouth. Patients who experience any of these side effects should stop taking Strattera and seek medical attention immediately.
The common side effects of Strattera include increased appetite, vomiting, constipation, stomach upset, nausea, and decreased appetite. The most serious side effects of Strattera include liver injury, increased liver enzymes, and increased risk of suicide. Some of the side effects of Strattera can be reversible, but they are generally mild and temporary. The most common side effects of Strattera are dry mouth, insomnia, blurred vision, and weight gain.
How do I take Strattera?
Take the tablet 1 to 3 hours before or after a meal. You should eat at least 1 hour before or 2 hours after taking Strattera. If you miss a meal, take it as soon as you remember. If it is close to the time for your next dose, skip the missed dose. Do not take two doses at the same time. Do not take two doses at the same time to make up for a missed dose. Swallow the tablets whole. Do not chew, crush, or break the tablets.
If you miss a dose, take it as soon as you remember. Do not take a double dose to make up for a missed dose.
If you miss the last dose of Strattera, take it as soon as you remember.
Are there any side effects of Strattera?
The most common side effects of Strattera are drowsiness, drowsiness, dry mouth, increased appetite, and weight gain. However, some people may experience drowsiness or dry mouth when taking Strattera. The most common side effects of Strattera are dry mouth, headache, and dizziness. Most people who experience these side effects are not using Strattera and may be experiencing mild to moderate side effects like nausea, drowsiness, decreased appetite, dry mouth, and weight gain.
What to do if I forget to take Strattera?
If you miss a dose of Strattera, take it as soon as you remember.
Strattera (atomoxetine) is a medication used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. It belongs to the family of selective norepinephrine reuptake inhibitors (SNRI), which work by increasing the levels of norepinephrine in the brain. Strattera works by increasing norepinephrine levels in the brain, which can help improve attention and focus in the bedroom. It is available only by prescription in the US and in many other countries.
Strattera is not approved by the Food and Drug Administration (FDA) for use in children, pregnant women, and people with certain medical conditions. Strattera is only for adults.
Strattera (atomoxetine) is a prescription medication. It’s not a controlled substance and is not regulated by the FDA. It works differently from other prescription drugs in that it doesn’t contain diclofenac and carbamazepine (Carbatrol) which are the same medications used in treatment of ADHD and narcolepsy.
Stade de France Pharmacy